Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¹é¼­ ³úÇϼöü Àü¿±¼¼Æ÷¿¡ ¹ÌÄ¡´Â Nitric Oxide SynthaseÀÇ ¿µÇâ¿¡ °üÇÑ ½ÇÇèÀû ¿¬±¸ An Experimental Study of Effects of Nitric Oxide Synthase on Rat Anterior Pituitary Gland

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1999³â 28±Ç 9È£ p.1264 ~ 1271
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÈ£±¹/Ho Kook Lee ȲµµÀ±/±èÀ±È­/¹Ú¿ë±¸/¾ç¹®È£/Do Yun Hwang/Youn Wha Kim/Yong Koo Park/Moon Ho Yang

Abstract

°á·Ð
º» ¿¬±¸ÀÇ ¸ñÀûÀº ¹é¼­ÀÇ ³úÇϼöü¿¡¼­ NOS°¡ Á¸ÀçÇÏ´Â ¼¼Æ÷ ¹× ¼ºÀåÈ£¸£¸ó¿¡ ¹ÌÄ¡´Â
¿µÇâÀ» ¾Ë¾Æº¸±â À§ÇÏ¿© º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù. ½ÇÇè¹æ¹ýÀº ¼ºÀå±âÀÇ ¹é¼­¿¡ »êÈ­Áú¼Ò °ø¿©
¹°ÁúÀÎ sodium nitroprusside¿Í s-nitro-acetyl-penicillamine, ±×¸®°í nitric oxide
synthase(NOS)ÀÇ ÀϹÝÀûÀÎ ¾ïÁ¦Á¦ÀÎ N-mono-methylamine°ú iNOSÀÇ ¾ïÁ¦Á¦ÀÎ
aminoguanidineÀ» Åõ¿©ÇÏ°í ³úÇϼöü¿¡¼­ÀÇ ¼ºÀåÈ£¸£¸óÀÇ º¯È­¸¦ Ç÷û¿¡¼­ ¹æ»ç¼± ¸é¿ªºÐ
¼®¹ýÀ» ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÏ°í ¾Æ¿ï·¯ NOS¿¡ ´ëÇÑ ¸é¿ªÁ¶Á÷È­ÇÐÀû ¿°»öÀ» ½ÃÇàÇÏ¿´´Ù. ¶ÇÇÑ,
³úÇϼöü¿¡¼­ mRNA¸¦ ºÐ¸®ÇÏ°í NOS¿¡ ´ëÇÑ ¿ªÀü»ç ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀÀ» ÀÌ¿ëÇÏ¿© ºÐÀÚ
»ý¹°ÇÐÀûÀ¸·Î NOS°¡ °¢°¢ÀÇ ½ÇÇ豺¿¡¼­ º¯È­ÇÏ´Â °ÍÀ» °üÂûÇÏ¿© ´ÙÀ½ÀÇ °á·ÐÀ» ¾ò¾ú´Ù.
1) »ý¸®½Ä¿°¼ö¸¸À» Åõ¿©ÇÑ ´ëÁ¶±º¿¡¼­ Ç÷û³» ¼ºÀåÈ£¸£¸óÀº 4.0¡¾0.58ng/§¢lÀ̾úÀ¸³ª »êÈ­
Áú¼Ò°ø¿©¹°ÁúÀ» Åõ¿©ÇÑ ±ºµé°£¿¡¼­´Â Â÷ÀÌ°¡ ¾ø¾ú°í NOS¿¡ ´ëÇÑ ¾ïÁ¦Á¦ÀÎ L-NA-ME¸¦
Åõ¿©ÇßÀ» ¶§´Â 32.0¡¾10.82ng/§¢, ±×¸®°í aminoguanidineÀ» Åõ¿©ÇÑ °æ¿ì´Â 31.67¡¾11.29ng/§¢
·Î Ç÷û³» ¼ºÀåÈ£¸£¸óÀÇ ¾çÀÌ Åë°èÇÐÀûÀ¸·Î À¯ÀÇÇÏ°Ô Áõ°¡ÇÏ¿´´Ù.
2) NOS¿¡ ´ëÇÑ ¸é¿ªÁ¶Á÷È­ÇÐÀû ¿°»ö¿¡¼­ Á¤»ó´ëÁ¶±º¿¡¼­´Â ³úÇϼöü Àü¾÷¿¡¼­ ´ë´Ù¼öÀÇ
¼ÒÆ÷¼º»ó¼¼Æ÷¿¡¼­ °­ÇÏ°Ô ¾ç¼ºÀ¸·Î ¿°»öµÇ¾úÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼Ò¼öÀÇ Àü¿°¼¼Æ÷¿¡¼­µµ ÀϺΠ¾à
ÇÏ°Ô ¿°»öµÇ¾úÀ¸³ª »êÈ­Áú¼Ò °ø¿©¹°ÁúÀ» Åõ¿©ÇÑ ±ºÀ̳ª NOS ¾ïÁ¦Á¦¸¦ Åõ¿©ÇÑ ±º¿¡¼­´Â ¿°
»öÁ¤µµÀÇ Â÷À̸¦ º¼ ¼ö ¾ø¾ú´Ù.
3) iNOS¿¡ ´ëÇÑ ¿ªÀü»ç ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀÀ» ½ÃÇàÇÑ °á°ú ´ëÁ¶±º¿¡ ºñÇؼ­ ´ëºÎºÐÀÇ ½Ç
Ç豺¿¡¼­´Â Â÷ÀÌ°¡ ¾ø¾úÀ¸³ª aminoguanidineÀ» Åõ¿©ÇÑ ½ÇÇ豺¿¡¼­¸¸ 222 base pair¿¡¼­
mRNA°¡ ´õ °­ÇÏ°Ô ¹ßÇöµÇ¾ú´Ù.
±×·¯¹Ç·Î ÀÌ»óÀÇ ¼Ò°ßÀ¸·Î ¹Ì·ç¾î º¸¾Æ NOS¸¦ ¾ïÁ¦ÇÒ ¶§ Ç÷û³» ¼ºÀåÈ£¸£¸óÀÌ Áõ°¡ÇÏ´Â
°ÍÀ» ¾Ë ¼ö ÀÖ¾úÀ¸³ª ´ëÁ¶±º¿¡ ºñÇØ NOS¿¡ ´ëÇÑ ¸é¿ªÁ¶Á÷È­ÇÐÀû ¿°»ö»ó Â÷À̸¦ °üÂûÇÏÁö
¸øÇÑ Á¡°ú iNOS¿¡ ´ëÇÑ ¿ªÀü»ç ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ¿¡¼­ ÀϺΠNOS ¾ïÁ¦Á¦¸¦ Åõ¿©ÇÑ ±º¿¡¼­
mRNA°¡ °­ÇÏ°Ô ³ªÅ¸³­ °ÍÀ¸·Î º¸¾Æ ¼ºÀåÈ£¸£¸ó ºÐºñÀÇ Á¤È®ÇÑ ±âÀüÀº ¹àÈ÷Áö ¸øÇÏ¿´À¸³ª
NOS°¡ ³úÇϼöüÀÇ ¼ºÀåÈ£¸£¸óÀ» Á¶ÀýÇÏ´Â ÀÛ¿ë¿¡ °ü¿©ÇÏ°í ÀÖÀ½Àº ¾Ë ¼ö ÀÖ¾ú´Ù.
#ÃÊ·Ï#
Objective : The nitric oxide synthases(NOS) are a group of isoenzymes that convert
L-arginine to L-citrulline and generate nitric oxide(NO). The constitutive form of NOS
is present in endothelium. adrenal gland, brain, and platelets, while the inducible form of
NOS is present in macrophages, hepatocytes. vascular smooth muscle cell and
endothelial cells. To determine whether NO has a role in anterior pituitary call function,
immunohistochemistry and molecular techniques tiers used to study NOS expression in
rat pituitary gland.
Materials and Methods : We treated the Fats with two NOS inhibitors :
N-mono-methyl amine(NMMA). Which is an inhibitor e¡¹ NOS activity anti
aminoguanidine. which a selective inhibitor Of the inducible NOS isoform anti two NO
donors ; sodium nitroprusside(SNP), s-nitro-acetyl-penicillamine(SNAP) as we11 as
L-arginine. Rat growth hormone was measured in the serum using radioimmunoassay
and NOS producing cells in the anterior lobe of the pituitary was detected by
immunohistochemical stains. Also mRNA was extracted from the pituitary and performed
RT-PCR using inducible NOS primer.
Results : Serum growth hormone levels were increased significantly by administration
of NOS inhibitors, such as NMMA and aminoguanidins. Immunohistochemical stains for
neuronal and inducible NOS showed strong positivity in the folliculostellate cells and
weak positivity in the anterior pituitary cells in the control and various experimental
groups. RT-PCR in inducible NOS showed more brighter band in the 222 base pairs in
the aminoguanidine treated group than normal control group.
Conclusion : These data suggest that pituitary NOS may play a pivotal role in the
control of growth hormone secretion.

Å°¿öµå

Nitric oxide synthase; Pituitary; Immunohistochemistry; RT-PCR; Rat;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS